Skip to main content
Clinical Trials/DRKS00000100
DRKS00000100
Not yet recruiting
未知

The influence of multimodal physical activity on cognition and everyday life competence in patients with early Alzheimer's disease - Sport & KOG

niversitätsklinikum EssenUniversität Duisburg-Essen0 sites300 target enrollmentMarch 24, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
G30
Sponsor
niversitätsklinikum EssenUniversität Duisburg-Essen
Enrollment
300
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 24, 2009
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum EssenUniversität Duisburg-Essen

Eligibility Criteria

Inclusion Criteria

  • diagnosis of Alzheimer's dementia according to NINCDS\-ADRDA respectively ICD 10
  • \-Mini\-Mental\-State\-Test (20 \- 25\) at screening
  • \-Hachinski Ischemia Scale \<\=4 at screening
  • \-CT or MRT, maximal 2 years old, compatible with Alzheimer's dementia
  • \-Geriatric Depression Scale (GDS) \<\=4 (15\-item scale)
  • \-ambulant patients
  • \-exercise ECG analysed by specialist in internal medicine
  • \-caregiver (contact 3 times a week, overall 5 hours a week), who can report the patient's state of health
  • \-informed consent form signed by patient and caregiver

Exclusion Criteria

  • \-diagnosis of a possible, probable or certain vascular dementia NINDS\-AIREN criteria
  • \-missing approval ability, missing ability to take part in intervention programme or missing compliance
  • \-intake of following drugs with change of dosage during the last 3 months before baseline: antidepressants, tranquilizer / sleeping pills, anti\-psychotica or anti\-epileptica
  • \-excessive alcohol, drug or medicament abuse. Diagnosis of drug abuse or drug addiction (ICD\-10\) as a primary clinical diagnosis, which indicates the initiation or continuation of a medical treatment of this disorder
  • \-clinically relevant neurologic or psychiatric diseases, such as severe depression, schizophrenia, epilepsy or Parkinson's disease
  • \-participation in a pharmaceutical trail 2 months before baseline
  • \-decompensated or poorly regulated diabetes
  • \-decompensated or poorly regulated hypertonia
  • \-cardiovascular event during the last 3 months e.g. cardiac catheterization, vascular surgery, acute coronary syndrome, myocardial infarction or unstable angina, clinical relevant cardiac dysrhythmia, cardiac surgery, angiography with stent implantation
  • \-other clinically significant aberrances in clinical, neurologic, laboratory medicine examination, clinically relevant ECG changes, which could impair the patient's health related to the trail

Outcomes

Primary Outcomes

Not specified

Similar Trials